Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $33.1300 (-7.22%) ($32.7100 - $36.3000) on Tue. Nov. 10, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.55% (three month average) | RSI | 50 | Latest Price | $33.1300(-7.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2.5% a day on average for past five trading days. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) IBB(52%) ARKG(49%) IWO(48%) IWM(44%) | Factors Impacting ATRA price | ATRA will decline at least -3.275% in a week (0% probabilities). VIXM(-17%) TLT(-14%) UUP(-7%) UNG(-3%) SHY(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.275% (StdDev 6.55%) | Hourly BBV | 0 () | Intraday Trend | -6.8% | | | |
|
5 Day Moving Average | $33.13(0%) | 10 Day Moving Average | $30.38(9.05%) | 20 Day Moving Average | $0(0%) | To recent high | -7.2% | To recent low | 38.7% | Market Cap | $2.462b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |